All In MedTech

Device Trial Radar · NCT05828979

Clinical Investigation to Assess a New Artificial Urinary Sphincter to Treat Urinary Incontinence in Women

Feasibility sTudy to Assess the URoMems Artificial uriNary Sphincter In the Treatment of Stress Incontinence in wOmeN

Last checked: Nov 19, 2026Latest source record: Apr 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

6

Planned (sponsor's estimate)

Start

May 2, 2023

Primary completion

Jan 23, 2025

Study completion Sep 2029

Sponsor

Lead sponsor
UroMems SASNot on our public-company list
Sponsor type
Industry
First posted
Apr 25, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective multicenter study designed to test the feasibility of the UroMems Artificial Urinary Sphincter in women

Conditions

  • Urinary Incontinence,Stress

Interventions

  • UroMems artificial urinary sphincterDevice

    Implantation of the device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of explants and revisions at 6 months after device activationTime frame: 6 months after device activation
  2. Rate of device activation successesTime frame: 5 weeks after device implantation

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • CHU Nantes

    Nantes, France

  • Groupe Hospitalier Pitié-Salpêtrière

    Paris, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.